123 related articles for article (PubMed ID: 1828377)
1. Comparative evaluation of in vitro activity of teicoplanin and vancomycin against coagulase negative methicillin resistant staphylococci isolated from high-risk patients.
Battista C; Panza N; Chiurazzi B; Romano A; Pacilio G; Amato G; Gargiulo F; Bolletti Censi M; Bocchetti M
Biomed Pharmacother; 1991; 45(1):43. PubMed ID: 1828377
[No Abstract] [Full Text] [Related]
2. [Comparative in vitro activity of glycopeptides against coagulase negative staphylococci isolated in pediatric hospital units].
Bourgeois F; Bingen E; Lambert-Zechovsky N
Pathol Biol (Paris); 1992 Jan; 40(1):36-9. PubMed ID: 1533278
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Staphylococcus aureus and coagulase-negative staphylococci with decreased sensitivity to glycopeptides as assessed by determination of MICs.
Vedel G; Leruez M; Lémann F; Hraoui E; Ratovohery D
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):820-2. PubMed ID: 2150815
[TBL] [Abstract][Full Text] [Related]
4. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
Watanakunakorn C
J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
[TBL] [Abstract][Full Text] [Related]
5. Anti-staphylococcal activity of teicoplanin, vancomycin, and other antimicrobial agents: the significance of methicillin resistance.
Del Bene VE; John JF; Twitty JA; Lewis JW
J Infect Dis; 1986 Aug; 154(2):349-52. PubMed ID: 2941491
[No Abstract] [Full Text] [Related]
6. Teicoplanin-resistant coagulase-negative staphylococci.
Arioli V; Pallanza R
Lancet; 1987 Jan; 1(8523):39. PubMed ID: 2879112
[No Abstract] [Full Text] [Related]
7. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.
Goldstein FW; Coutrot A; Sieffer A; Acar JF
Antimicrob Agents Chemother; 1990 May; 34(5):899-900. PubMed ID: 2141780
[TBL] [Abstract][Full Text] [Related]
8. Glycopeptide resistance in coagulase-negative staphylococci.
Biavasco F; Vignaroli C; Varaldo PE
Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):403-17. PubMed ID: 10947214
[TBL] [Abstract][Full Text] [Related]
9. The effect of medium and inoculum on the activity of vancomycin and teicoplanin against coagulase-negative staphylococci.
Felmingham D; Solomonides K; O'Hare MD; Wilson AP; Grüneberg RN
J Antimicrob Chemother; 1987 Oct; 20(4):609-10. PubMed ID: 2960645
[No Abstract] [Full Text] [Related]
10. In vitro susceptibility of Staphylococci and Enterococci to vancomycin and teicoplanin.
Guzek A; Korzeniewski K; Nitsch-Osuch A; Rybicki Z; Prokop E
Adv Exp Med Biol; 2013; 788():125-32. PubMed ID: 23835969
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
Kenny MT; Dulworth JK; Brackman MA
Diagn Microbiol Infect Dis; 1991; 14(1):29-31. PubMed ID: 1826479
[TBL] [Abstract][Full Text] [Related]
12. [Isolation of coagulase-negative teicoplanin-resistant staphylococci].
Riegel P; Ellis A; Jehl F
Presse Med; 1990 Jun; 19(22):1053. PubMed ID: 2141162
[No Abstract] [Full Text] [Related]
13. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
Thamlikitkul V
J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
[TBL] [Abstract][Full Text] [Related]
14. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci.
Sieradzki K; Villari P; Tomasz A
Antimicrob Agents Chemother; 1998 Jan; 42(1):100-7. PubMed ID: 9449268
[TBL] [Abstract][Full Text] [Related]
15. In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci.
Raymond J; Vedel G; Bergeret M
J Antimicrob Chemother; 1996 Dec; 38(6):1067-71. PubMed ID: 9023655
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients.
Maugein J; Pellegrin JL; Brossard G; Fourche J; Leng B; Reiffers J
Antimicrob Agents Chemother; 1990 May; 34(5):901-3. PubMed ID: 2141781
[TBL] [Abstract][Full Text] [Related]
17. [In vitro activity of vancomycin and teicoplanin against gram-positive cocci].
Bezian MC; Ribou G; Masquelier B
Pathol Biol (Paris); 1992 May; 40(5):461-5. PubMed ID: 1386667
[TBL] [Abstract][Full Text] [Related]
18. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)].
Kayaokay Y; Hasçelik G; Gür D; Akalin E
Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050
[TBL] [Abstract][Full Text] [Related]
19. Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci.
Bourgeois I; Pestel-Caron M; Lemeland JF; Pons JL; Caron F
Antimicrob Agents Chemother; 2007 Feb; 51(2):740-3. PubMed ID: 17116684
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of susceptibility of methicillin resistant Staphylococcus aureus strains to vancomycin].
Młynarczyk G; Młynarczyk A; Meisel-Mikołajczyk F
Med Dosw Mikrobiol; 1995; 47(3-4):133-9. PubMed ID: 8833924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
